help button home button Endocrine Society JCEM
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS

Journal of Clinical Endocrinology & Metabolism, doi:10.1210/jc.2005-1407
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
91/3/1087    most recent
Author Manuscript (PDF)
Right arrow Submit a related Letter to the Editor
Right arrow Purchase Article
Right arrow View Shopping Cart
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Copyright Permission
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Ikegami, H.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Ikegami, H.
Right arrowPubmed/NCBI databases
*Gene*GEO Profiles
*HomoloGene*UniGene
*Substance via MeSH
Medline Plus Health Information
*Diabetes Type 1
Related Collections
Right arrow Thyroid
Right arrow Autoimmunity
Right arrow Diabetes and Insulin
The Journal of Clinical Endocrinology & Metabolism Vol. 91, No. 3 1087-1092
Copyright © 2006 by The Endocrine Society

The Association of CTLA4 Polymorphism with Type 1 Diabetes Is Concentrated in Patients Complicated with Autoimmune Thyroid Disease: A Multicenter Collaborative Study in Japan

Hiroshi Ikegami, Takuya Awata, Eiji Kawasaki, Tetsuro Kobayashi, Taro Maruyama, Koji Nakanishi, Akira Shimada, Shin Amemiya, Yumiko Kawabata, Susumu Kurihara, Shoichiro Tanaka, Yasuhiko Kanazawa, Mie Mochizuki, Toshio Ogihara on behalf of the Japanese Study Group on Type 1 Diabetes Genetics1

Department of Geriatric Medicine (H.I., Y.Kaw., T.O.), Osaka University Graduate School of Medicine, Yamadaoka, Suita, Osaka 565-0871, Japan; Division of Endocrinology and Diabetes, Department of Medicine (T.A., S.K.), Saitama Medical School, Saitama 350-0495, Japan; Department of Metabolism/Diabetes and Clinical Nutrition (E.K.), Nagasaki University Hospital of Medicine and Dentistry, Nagasaki 852-8501, Japan; Third Department of Internal Medicine (T.K., S.T.) and Department of Pediatrics (S.A., M.M.), Interdisciplinary Graduate School of Medical and Engineering, University of Yamanashi, Yamanashi 409-3898, Japan; Department of Internal Medicine (T.M.), Saitama Social Insurance Hospital, Saitama 330-0074, Japan; Department of Endocrinology and Metabolism (K.N.), Toranomon Hospital, Tokyo 105-8470, Japan; and Department of Internal Medicine (A.S., Y.Kan.), Keio University School of Medicine, Tokyo 160-8582, Japan

Address all correspondence and requests for reprints to: Hiroshi Ikegami, M.D., Ph.D., Department of Geriatric Medicine, Osaka University Graduate School of Medicine, Yamadaoka, Suita, Osaka 565-0871, Japan. E-mail: ikegami{at}geriat.med.osaka-u.ac.jp.

Context: Transracial studies are a powerful tool for genetic association studies of multifactorial diseases, such as type 1 diabetes. The low incidence of type 1 diabetes in Asian countries, however, makes it difficult to perform large-scale studies in Asia.

Objective: To overcome this, we have assembled a multicenter study group in Japan and studied the association of CTLA4 polymorphisms with type 1 diabetes relative to autoimmune thyroid disease (AITD) phenotypes.

Subjects: Subjects included a total of 1837 samples, including 1114 cases (769 with type 1 diabetes and 345 with AITD) and 723 control subjects.

Methods: The +6230G>A and +49G>A polymorphisms of CTLA4 as well as HLA-DRB1 and -DQB1 were genotyped.

Results: The +6230G>A polymorphism was significantly associated with type 1 diabetes complicated with AITD (odds ratio, 1.54; P = 0.027) and with AITD alone (odds ratio, 1.31; P = 0.045) but not with type 1 diabetes without AITD. The association with type 1 diabetes positive for autoantibodies to both pancreatic islets and thyroid was particularly strong (odds ratio, 1.87; P = 0.001). Type 1 diabetic patients with the disease-associated GG genotype were characterized by a significantly higher frequency of AITD (P = 0.013), of positivity for both AITD and antiislet autoantibody (P = 0.00086), and of high-risk HLA genotypes (P = 0.034).

Conclusions: Given the high frequency of AITD in patients with type 1 diabetes, these data suggest the possibility that the association of CTLA4 with type 1 diabetes in previous studies may have been secondary to AITD, suggesting the importance of subclassification of type 1 diabetes relative to AITD in genetic studies.




This article has been cited by other articles:


Home page
Diabetes CareHome page
E. Kawasaki, A. Imagawa, H. Makino, M. Uga, N. Abiru, T. Hanafusa, Y. Uchigata, and K. Eguchi
Differences in the Contribution of the CTLA4 Gene to Susceptibility to Fulminant and Type 1A Diabetes in Japanese Patients
Diabetes Care, August 1, 2008; 31(8): 1608 - 1610.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
K. Hunter, D. Rainbow, V. Plagnol, J. A. Todd, L. B. Peterson, and L. S. Wicker
Interactions between Idd5.1/Ctla4 and Other Type 1 Diabetes Genes
J. Immunol., December 15, 2007; 179(12): 8341 - 8349.
[Abstract] [Full Text] [PDF]


Home page
J. Clin. Endocrinol. Metab.Home page
F. K. Kavvoura, T. Akamizu, T. Awata, Y. Ban, D. A. Chistiakov, I. Frydecka, A. Ghaderi, S. C. Gough, Y. Hiromatsu, R. Ploski, et al.
Cytotoxic T-Lymphocyte Associated Antigen 4 Gene Polymorphisms and Autoimmune Thyroid Disease: A Meta-Analysis
J. Clin. Endocrinol. Metab., August 1, 2007; 92(8): 3162 - 3170.
[Abstract] [Full Text] [PDF]


Home page
J. Clin. Endocrinol. Metab.Home page
T. Awata, E. Kawasaki, H. Ikegami, T. Kobayashi, T. Maruyama, K. Nakanishi, A. Shimada, H. Iizuka, S. Kurihara, M. Osaki, et al.
Insulin Gene/IDDM2 Locus in Japanese Type 1 Diabetes: Contribution of Class I Alleles and Influence of Class I Subdivision in Susceptibility to Type 1 Diabetes
J. Clin. Endocrinol. Metab., May 1, 2007; 92(5): 1791 - 1795.
[Abstract] [Full Text] [PDF]


Home page
J. Clin. Endocrinol. Metab.Home page
M. Tsurumaru, E. Kawasaki, H. Ida, K. Migita, A. Moriuchi, K. Fukushima, T. Fukushima, N. Abiru, H. Yamasaki, S. Noso, et al.
Evidence for the Role of Small Ubiquitin-Like Modifier 4 as a General Autoimmunity Locus in the Japanese Population
J. Clin. Endocrinol. Metab., August 1, 2006; 91(8): 3138 - 3143.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Endocrinology Endocrine Reviews J. Clin. End. & Metab.
Molecular Endocrinology Recent Prog. Horm. Res. All Endocrine Journals
Copyright © 2006 by The Endocrine Society